Trial Information
Inclusion Criteria:
- Non-small cell lung cancer
- Available plasma and pathologically confirmed tissue slices(pre-chemo and pre-radio
therapy)
- Informed Consent
Exclusion Criteria:
- N/A
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
To determine the consistence of EGFR mutation status in paired tissue and plasma samples
Outcome Time Frame:
3 months
Safety Issue:
No
Principal Investigator
Mengzhao Wang, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Peking Union Medical College Hospital
Authority:
China: Ministry of Health
Study ID:
LCC001
NCT ID:
NCT01382992
Start Date:
June 2010
Completion Date:
Related Keywords:
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Non-Small-Cell Lung
- erbB-1
- Carcinoma
- Carcinoma, Non-Small-Cell Lung